- Research works
- 52 ▼ 53% vs 2013–17
- Citations
- 2.1k 41.3 per fractional work
- Top-10% rate
- 25.0% record average 16.5%
- Open access
- 40% world 28%
Not ranked overall: Polymun (Austria) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Which keywords describe research at Polymun (Austria)?
By fractional works in all years, weighted toward what it does more of than the world: Glycosylation, Biopharmaceutical Production, Antiretroviral Therapy, Mammalian Cells, Recombinant Protein, Monoclonal Antibodies, Therapeutic Antibodies and Vaccine.
- Drug Resistance
- Nanocarriers
- Lipid Rafts
- Immune System
- HIV Infection
- Stability
- Plant Molecular Farming
- Biomedical Applications
- Viral Vectors
- Genomic Integration
- Cancer
- Fc Receptors
- AIDS
- Gene Therapy
- Immune Response
- Antibodies
- Nanoparticles
- Monoclonal Antibodies
- Mammalian Cells
- Antiretroviral Therapy
- Glycosylation
- Biopharmaceutical Production
- Recombinant Protein
- Therapeutic Antibodies
- Vaccine
- Biopharmaceuticals
- Recombinant Proteins
- HIV
- Antibody Engineering
- Immune Activation
- Drug Delivery
- AAV
- Cancer Therapy
- Immunogenicity
- Protein Aggregation
- Vaccine Antigens
- Glycans
- Mucins
- Membrane Lipids
- Surface Engineering
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Glycosylation11▲ 95×3 topics
- Antiretroviral Therapy6▲ 49×4 topics
- Biopharmaceutical Production6▲ 147×2 topics
- Mammalian Cells6▲ 283×1 topic
- Recombinant Protein6▲ 283×1 topic
- Monoclonal Antibodies6▲ 75×3 topics
- Therapeutic Antibodies6▲ 83×2 topics
- Nanoparticles4▲ 6.4×10 topics
- Vaccine4▲ 20×5 topics
- Antibodies4▲ 91×2 topics
- Biopharmaceuticals4▲ 117×3 topics
- Immune Response4▲ 13×5 topics
- Recombinant Proteins4▲ 145×2 topics
- Gene Therapy4▲ 29×3 topics
- HIV4▲ 58×2 topics
- AIDS4▲ 130×1 topic
- Antibody Engineering4▲ 67×1 topic
- Fc Receptors4▲ 67×1 topic
- Immune Activation4▲ 74×1 topic
- Cancer3▲ 4.6×10 topics
- Drug Delivery3▲ 13×5 topics
- Genomic Integration3▲ 53×2 topics
- AAV3▲ 80×1 topic
- Viral Vectors3▲ 80×1 topic
- Cancer Therapy2▲ 7.4×3 topics
- Biomedical Applications2▲ 3.7×4 topics
- Immunogenicity2▲ 80×2 topics
- Plant Molecular Farming2▲ 157×1 topic
- Protein Aggregation2▲ 49×1 topic
- Stability2▲ 20×1 topic
- Vaccine Antigens2▲ 157×1 topic
- HIV Infection2▲ 28×2 topics
- Glycans2▲ 37×1 topic
- Immune System2▲ 9.7×2 topics
- Mucins2▲ 37×1 topic
- Lipid Rafts1▲ 38×1 topic
- Membrane Lipids1▲ 45×1 topic
- Nanocarriers1▲ 64×1 topic
- Surface Engineering1▲ 24×1 topic
- Drug Resistance1▲ 8.2×1 topic
Which research topics does Polymun (Austria) publish most on?
By volume in 2022–2025: HIV Research and Treatment, Immunotherapy and Immune Responses, Monoclonal and Polyclonal Antibodies Research and Spaceflight effects on biology.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 HIV Research and Treatment Virology 0 works
- 2 Immunotherapy and Immune Responses Immunology 0 works
- 3 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 0 works
- 4 Spaceflight effects on biology Physiology 0 works
- 5 Cardiovascular and Diving-Related Complications Pulmonary and Respiratory Medicine 0 works
- 6 RNA Interference and Gene Delivery Molecular Biology 0 works
- 7 High Altitude and Hypoxia Genetics 0 works
- 8 Glycosylation and Glycoproteins Research Molecular Biology 0 works
- 9 HIV/AIDS drug development and treatment Infectious Diseases 0 works
- 10 Protein purification and stability Molecular Biology 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Polymun (Austria)'s research output changed?
Output in 2018–2022 was 53% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Klosterneuburg
- Institute of Science and Technology Austria
- Konrad Lorenz Institute for Evolution and Cognition Research
- Höhere Bundeslehranstalt und Bundesamt für Wein- und Obstbau
- Electrovac (Austria)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.